Societal barriers to chemoprevention
4 Aug 2016
Societal barriers to chemoprevention
Surrogate endpoint biomarkers in research
Update on CaPP3 in high risk populations
COMMD1 pathway activated by aspirin restores apoptosis in colorectal cancer
Breast cancer in the 21st century
Modern antiematogenic therapy from 5-HT3 to NK-1 antagonists
Obesity promotes pancreatic cancer progression and resistance
ERß expression predicts breast cancer risk in hyperplasia
Mouse models of lung cancer
Patient perspectives in precision medicine: 'No innovation about us without us'
A global perspective on infections related to cancer
MetAL trial for prostate cancer